Viewing StudyNCT00308087



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00308087
Status: TERMINATED
Last Update Posted: 2013-12-27
First Post: 2006-03-28

Brief Title: Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma a Form of Non-Hodgkins Lymphoma
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-05
Start Date Type: None
Primary Completion Date: 2009-06
Primary Completion Date Type: ACTUAL
Completion Date: 2009-06
Completion Date Type: ACTUAL
First Submit Date: 2006-03-28
First Submit QC Date: March 28 2006
Study First Post Date: 2006-03-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2010-08-30
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-02
Last Update Post Date: 2013-12-27
Last Update Post Date Type: ESTIMATED